Differential diagnosis of Kidney mass
-
Upload
rombergs-sign -
Category
Documents
-
view
1.645 -
download
2
Transcript of Differential diagnosis of Kidney mass
![Page 1: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/1.jpg)
![Page 2: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/2.jpg)
Case
A 55 year old man presents to his primary care physician complaining of gross hematuria and right loin pain. PE reveals a flank mass. The CBC level hemoglobin level of 21g/dl and polycythemia. Ultrasound shows a 6 cm mass at the upper pole of the right kidney.
![Page 3: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/3.jpg)
ImpressionRenal cancer
--classic triad of signs and symptoms includes gross hematuria; dull, aching flank pain; and a smooth, firm, palpable flank mass. Colicky pain may accompany the passage of clots
--Other findings include fever, CVA tenderness, and increased blood pressure. In advanced disease, the patient may develop weight loss, nausea and vomiting, and leg edema with varicoceles.
![Page 4: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/4.jpg)
a.) Transitional cell cancer
b.) Renal calculi
c.) Renal papillary adenoma
d.) IgA Nephropathy
![Page 5: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/5.jpg)
![Page 6: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/6.jpg)
TRANSITIONAL CELL CARCINOMA
Arising from the transitional epithelium lining
The most common type of bladder cancer cancer of the uretercancer of the Urethracancer of the urachus
The second most common type of kidney cancer
(Renal Pelvic)
![Page 7: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/7.jpg)
SIGNS & SYMPTOMS
Hematuria
Pain on urination (without evidence of urinary tract infection)
Need to urinate frequently
Pelvic pain , Back pain, Abdominal pain
Signs of urinary tract obstruction
![Page 8: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/8.jpg)
![Page 9: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/9.jpg)
![Page 10: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/10.jpg)
![Page 11: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/11.jpg)
![Page 12: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/12.jpg)
high mitotic rate
![Page 13: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/13.jpg)
(UROLITHIASIS)
![Page 14: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/14.jpg)
Definition
Urolithiasis is the formation of calculi , or the condition associated with urinary calculi. The term calculi is synonymous with uroliths, stones, or crystals.
![Page 15: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/15.jpg)
Clinical SignsMay observe any of the following:
Difficulty urinating. Cloudy urine. Dampness of fur from urine around perineum. Foul odor. Bladder distention. Hematuria (blood in urine). Absence of urination. Frequent licking or nipping at genitals. Listlessness or hunched posture. Poor appetite. Dehydration. Signs of colicky type pain (intermittent spasms of pain).
![Page 16: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/16.jpg)
Etiology Urolithiasis is the presence of
uroliths/calculi (stones) in the urinary tract. These calculi are formed by deposits of polycrystalline aggregates composed of varied amounts of crystalloid and organic matrix. They can vary in size and may be found anywhere in the urinary tract from the kidney to the bladder.
![Page 17: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/17.jpg)
For stone formation to occur it requires saturated urine dependent upon urine pH, and the concentration of the solute. Different types of stones are: Struvite, which is made up of magnesium
ammonium phosphate. They are found in highly alkaline urine and often a concurrent urinary tract infection is present. They tend to be the most common type of urolith.
![Page 18: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/18.jpg)
Calcium oxalate, and Cystine, found in acidic urine.
Ammonium acid urate, and Silicate uroliths, found in neutral to acidic urine.
![Page 19: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/19.jpg)
Frequency
United StatesRenal calculi occur in 5-12% of the
American population, and they are bilateral in 10-15% of patients. The prevalence of urinary lithiasis is as high as 2-3% in the general population.
InternationalA slightly lower prevalence of urinary stones
is found in less developed countries, possibly because of diets lower in protein.
![Page 20: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/20.jpg)
RaceUrinary stones occur more often in white populations
than in black populations. They are also more prevalent in highly developed countries, possibly as a result of a higher protein diet.
SexMales are at a greater risk than females, with a
male-to-female ratio of 3:1 (except for struvite stones and in black populations).
AgeStones are uncommon but not unknown in children.
The peak age for development is in persons aged 40-60 years.
![Page 21: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/21.jpg)
Presentation
Acute ureteral obstruction by stone causes severe colicky (intermittent) flank pain that can radiate throughout the groin, testicles, back, and periumbilical region. Some patients with renal calculi may have no symptoms at all.
![Page 22: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/22.jpg)
Hematuria usually occurs. It can be intermittent or persistent and microscopic or gross. However, as many as 10% of patients with acute stones may not have hematuria.
Occasionally, recurrent infection may result in pyelonephritis or abscess. Stones can result in renal scarring, damage, and renal failure.
![Page 23: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/23.jpg)
RENAL PAPILLARY ADENOMAaka:
Renal papillary adenomaTubulo-papillary adenoma
--small,discrete proliferations of papillary or tubulo-papillary epithelium in the renal cortex which theoretically have no metastatic potential.
![Page 24: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/24.jpg)
Size
--size criterion in this definition is arbitrary and has become progressively smaller, from 1-3cm in early autopsy series, to more current consensus definitions restricting the lesions to less than 0.5cm
![Page 25: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/25.jpg)
Epidemiology
-- common (7% of nephrectomy specimens and 10-40% of autopsies)
--the lesions are more common in older patients (10% of patients <40 years; 40% in those >70 years).
--associated with prolonged hemodialysis and acquired cystic disease.
![Page 26: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/26.jpg)
Epidemiology
--often occur coincidentally with papillary renal cell carcinoma(PRCC)
○ papillary adenomas in surgical specimens demonstrated that nearly 50% of adenomas were identified in patients with PRCC; less than 10% were present in the setting of other renal diseases including other renal neoplasms and end-stage renal disease
![Page 27: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/27.jpg)
Morphologic basis epithelial lesions with a tubulo-papillary
architecture measuring less than 0.5cm and of low nuclear grade
Grossly, they are pale tan to grey, well-circumscribed, solid nodules in the renal cortex.
Histologically--composed of varying amounts of tubules and papillae lined by cuboidal cells with scant amphophilic to basophilic cytoplasm.
nuclei demonstrate no atypia
![Page 28: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/28.jpg)
Prognosis
Renal papillary adenomas theoretically have no metastatic potential.
![Page 29: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/29.jpg)
![Page 30: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/30.jpg)
IgA NephropathyIgA Nephropathy
• Most common cause of glomerulonephritis in the world
• Common in France, Japan, Italy and Austria
• Affects children and young adults (mostly males)
![Page 31: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/31.jpg)
Clinical ManifestationsClinical Manifestations Recurrent gross hematuria
Onset may follow a respiratory infection
Predominantly nephritic
Associated with Celiac Sprue and Henoch-Schonlein purpura
![Page 32: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/32.jpg)
PathogenesisPathogenesis
• The mechanism is unknown. There is a possible entrapment of circulating immune complexes with activation of the alternate complement pathway. There is also a possible genetic predisposition.
![Page 33: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/33.jpg)
IgA NephropathyIgA Nephropathy
Light microscopyLight microscopy
Variable
Normal
Mesangial proliferation
![Page 34: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/34.jpg)
IgA NephropathyIgA Nephropathy
Immunofluorescence: Immunofluorescence:
mesangial deposits of IgA and C3
Electron microscopy:Electron microscopy:
mesangial immune complex deposits
Prognosis:Prognosis:
many cases slowly progress to renal failure over 25
years
![Page 35: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/35.jpg)
![Page 36: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/36.jpg)
Renal cell carcinoma (RCC) comprises 5% of epithelial cancers with 38,000 new cases diagnosed in the U.S. this year.
The incidence of RCC has been steadily rising over the past 30 years. The majority (75%) of cases are clear-cell RCC.
![Page 37: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/37.jpg)
Clear Cell Carcinoma
Loss of the sequences of the short arm of chromosome 3.
Occurs by deletion or unbalanced chromosomal translocation resulting in the loss of chromosome 3 spanning 3p12 to 3p26
This region harbors the VHL gene 3p25.3
![Page 38: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/38.jpg)
VHL is a tumor-suppressor gene that targets the Hypoxia-Inducible Factor (HIF-1).
When VHL is mutated, HIF-1 levels remain high.
Binding of HIF to VHL is regulated by proline hydroxylation in a reaction involving 2-oxoglutarate, ferrous iron, and prolyl hydroxylase.
In SDH mutations, accumulation of succinate directly inhibits proline hydroxylase and HIF- levels rise
![Page 39: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/39.jpg)
Papillary Carcinoma
Not associated with 3p deletions.
Most common cytogenetic abnormalities are trisomies 7, 16 and 17.
Chromosome 7 encompasses the locus for MET, a protooncogene that serves as the tyrosine kinase receptor for HGF.
![Page 40: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/40.jpg)
Mutations of MET, a HIF target gene, cause type I papillary renal cancer
Another pathway of HIF accumulation and RCC development involves Krebs cycle enzyme mutations: succinate
dehydrogenase (SDH)-B mutations [16] cause clear-cell RCC, while mutations of fumarate hydratase [17] cause type II papillary cancer.
![Page 41: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/41.jpg)
![Page 42: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/42.jpg)
In its early stages, renal cell cancer usually causes no noticeable
symptoms. Symptoms may occur only when the cancer grows and begins to press on surrounding
tissues or spread to other parts of the body. The symptoms vary
considerably from person to person.
![Page 43: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/43.jpg)
Classic triad: Hematuria
Flank Pain
Palpable (abdominal) mass
The classic triad occurs in 10 to 20% of patients
![Page 44: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/44.jpg)
![Page 45: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/45.jpg)
![Page 46: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/46.jpg)
Other Presenting Signs and Symptoms
Weight loss Fever Malaise Weakness Anemia Loin Pain
Varicocele – enlargement of testicle
Night sweats Constipation
![Page 47: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/47.jpg)
PARANEOPLASTIC SYNDROMES(abnormal hormone production)
Polycythemia Hypercalcemia Hypertension Hepatic
dysfunction Feminization or
masculinization
Cushing Syndrome
Eosinophilia Leukemoid
reactions Amyloidosis
![Page 48: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/48.jpg)
A common characteristic of this tumor is its tendency to metastasize widely before giving rise to any local symptoms or signs.
Common locations of metastasis:
1. Lungs (more than 50%)
2. Bones (33%)
3. Regional lymph nodes, liver, adrenals, brain
![Page 49: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/49.jpg)
![Page 50: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/50.jpg)
![Page 51: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/51.jpg)
Diagnosis By Signs and symptoms ( Note: early
kidney cancers do not usually cause any signs or symptoms, but larger ones may).
Classic triad (10-15%)
1. Hematuria (blood in the urine), 2. flank pain 3. abdominal mass
![Page 52: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/52.jpg)
- detailed medical review of past health state men ages 50-70 Family history of the disease Smoking Von Hippel-Lindau disease ( Abdominal pain Abnormal urine color (dark, rusty, or brown) Back pain Blood in the urine Emaciated, thin, malnourished appearance
![Page 53: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/53.jpg)
Enlargement of the veins around a testicle (varicocele) Flank pain Swelling or enlargement of the abdomen Unintentional weight loss of more than 5% of body weight Constipation Cold intolerance Excessive hair growth in females Paleness Vision abnormalities
![Page 54: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/54.jpg)
Palpation: abdominal mass
Vital signs: Temp: (high- FEVER)
BP: High blood pressure
![Page 55: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/55.jpg)
Lab tests- CBC
Polycythemia (5%)
Anaemia resulting from depression of erythropoietin (5%)
![Page 56: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/56.jpg)
Lab tests Urinalysis (Urine tests)- check for several
indicators of the cancer such as blood, sugar, proteins, and bacteria.
RESULT: Abnormal urine color (dark, rusty, or brown) Blood in the urine
Blood chemistry tests- (kidney cancer can affect the levels of certain chemicals in the blood.
creatinine
![Page 57: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/57.jpg)
Imaging tests
![Page 58: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/58.jpg)
CT scan
Tumor in the left kidney Tumor in the kidney metastasis from lung CA
![Page 59: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/59.jpg)
Computed tomography(CT) similar with an x-ray test, it creates a detailed cross-
sectional image of the body; one of the most useful tests for finding and looking at a mass inside your kidney, useful in checking whether or not a cancer has spread to organs and tissues beyond the kidney.
precise information about the size, shape, and position of a tumor, and can help find enlarged lymph nodes that might contain cancer
RESULT: enhancement will be noted, and will highlight the tumor relative to normal renal parenchyma
![Page 60: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/60.jpg)
Magnetic resonance imaging(MRI)
provide detailed images of soft tissues in the body.
MRI scans use radio waves and strong magnets instead of x-rays.
provide a better picture of blood vessels Result: enhancement will be noted, and will
highlight the tumor relative to normal renal parenchyma
![Page 61: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/61.jpg)
Abdominal MRI
![Page 62: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/62.jpg)
Ultrasound or ultrasonography
safe, noninvasive and brief test that can detect tumors
a medical technique that uses high-frequency sound waves to create an interior image of the body on a special computer screen
helpful in determining if a kidney mass is solid or filled with fluid
![Page 63: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/63.jpg)
Abdominal ultrasound
![Page 64: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/64.jpg)
Positron emission tomography (PET scan)
provides useful information about the tumor location and how far the cancer has spread
uses radioactive glucose (known as fluorodeoxyglucose or FDG) to locate the cancer, because the cancerous cells absorb a higher amount of this substance than normal tissues.
useful to see if the cancer may have spread to lymph nodes near the kidney
![Page 65: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/65.jpg)
Intravenous pyelogram(IVP) special x-ray examination of the kidneys, bladder,
and ureters (the tubes that carry urine from the kidneys to the bladder).
Evaluate: Blood in the urine Flank pain (possibly due to kidney stones) Tumors
![Page 66: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/66.jpg)
Angiography
uses a contrast dye. This contrast agent is absorbed by the cancerous cells and displayed on an angiogram
help a surgeon plan surgery in some patients who need blood vessels mapped before the operation
also help diagnose renal cancers since the blood vessels usually have a special appearance with this test
![Page 67: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/67.jpg)
Renal angiogram
![Page 68: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/68.jpg)
Others…(help determine if the cancer has spread
(metastasized) to other parts of the body) chest x-rays bone scans 30% of patients with renal carcinoma present with
metastatic disease.
![Page 69: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/69.jpg)
BoNe ScAn
![Page 70: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/70.jpg)
Biopsy if imaging test results are not conclusive
enough to warrant removing a kidney confirm the diagnosis of cancer if a person’s
health is too poor for surgery and other local treatments
Fine needle aspiration -is performed only if the tumor can be easy reached; most used procedure of removing a sample of tissue
Core needle biopsy - removing a small cylinder of tumor tissue.
![Page 71: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/71.jpg)
Fuhrman grade
describe how aggressive the cancer is likely to be
The grade is based on how closely the cancer cells’ nuclei (part of a cell in which DNA is stored) look like those of normal kidney cells.
![Page 72: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/72.jpg)
![Page 73: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/73.jpg)
![Page 74: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/74.jpg)
Gross examination shows a yellowish, multilobulated tumor in the renal cortex, which frequently contains zones of necrosis, hemorrhage and scarring.
![Page 75: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/75.jpg)
![Page 76: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/76.jpg)
They usually have a gross yellow color and tumor cells resemble clear cells of the adrenal cortex but in truth, these tumors arise from the tubular epithelium and are therefore renal adenocarcinomas
![Page 77: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/77.jpg)
Kidney: Organ is 5-6 inches in length, and covered with fat
![Page 78: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/78.jpg)
![Page 79: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/79.jpg)
When assessing the gross anatomy:
Calyx and Ureter:
Is there anything blocking it? NOParenchyma
Can you delineate the cortex from the medulla (normal ratio of 1:3 or 1:4)? NOLight tan color of lesion - the lighter the color
of the lesion, the more packed it is with cellsPresence of ulceration? YES (encircled)
![Page 80: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/80.jpg)
![Page 81: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/81.jpg)
Renal cell carcinoma
Clear cell carcinoma
composed of large cells with clear or granular cytoplasm, and prominent vasculature
![Page 82: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/82.jpg)
Clear cell
![Page 83: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/83.jpg)
Renal cell carcinoma
The cells have a clear cytoplasm and you can see their borders easily. Some of the clear staining is due to lipid, which make the tumors look yellow grossly. Like most renal cell carcinomas, this tumor is rich in blood vessels.
![Page 84: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/84.jpg)
Renal cell carcinoma
Acinar tubule formation is noted Aggregates of mononuclear infiltrates
are also seen
![Page 85: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/85.jpg)
Renal cell carcinoma
![Page 86: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/86.jpg)
Renal cell carcinoma
![Page 87: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/87.jpg)
Renal cell carcinoma
![Page 88: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/88.jpg)
Renal cell carcinoma
![Page 89: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/89.jpg)
Clear cell
![Page 90: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/90.jpg)
Where does renal cell carcinomas arises? Renal cell carcinomas arises in the
proximal tubule cells or the renal epithelium.
Some said that it arises in the adrenal glands.
![Page 91: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/91.jpg)
![Page 92: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/92.jpg)
Clear cell carcinoma
This is the most common type, accounting for 70% to 80% of renal cell cancers.
On histologic examinations, the tumors are made up of cells with clear or granular cytoplasm and are nonpapillary.
![Page 93: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/93.jpg)
The neoplastic cells are characterized by a clear cytoplasm surrounded by a distinct cell membrane, but eosinophilic cells could be predominant.
Usually tumors has an alveolar or acinar pattern.
There is a network of delicate interconnecting capillaries or sinusoidal stroma supported by a network of thin reticulin fibers.
![Page 94: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/94.jpg)
Clear cell carcinoma
![Page 95: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/95.jpg)
Papillary carcinoma
Accounts for 10% to 15% or renal cancers.
Papillary RCC consists predominantly of papillary or tubulopapillary architecture.
The neoplastic cells are cuboidal or columnar with eosinophilic granular cytoplasm, but foci of clear cells could be observed.
![Page 96: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/96.jpg)
Fine fibrovascular stalks are present.
The stroma contains plasma cells, lymphocytes, neutrophils, and macrophages with focal or diffuse accumulation of foamy
macrophages in the stromal spaces.
Psammoma bodies are identifiable.
![Page 97: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/97.jpg)
Papillary carcinoma
![Page 98: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/98.jpg)
Chromophobe renal carcinoma
Represents 5% of renal cell cancers.
Composed of cells with prominent cell membranes and pale eosinophilic cytoplasm, usually with a halo around the nucleus
![Page 99: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/99.jpg)
Nuclei are central, and some are binucleated.
The cytoplasm is slighty positive for Periodic Acid Schiff and strongly positive for Hale's acid iron colloid stain.
In all of these tumors, areas of necrosis,
hemorrhage, and fibrosis could be identified
![Page 100: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/100.jpg)
Chromophobe renal carcinoma
![Page 101: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/101.jpg)
Collecting duct (Bellini duct) carcinoma
Represents approximately 1% or less of renal epithelial neoplasms.
Arise from collecting duct cells in the medulla.
These tumors are characterized by nests of malignant cells enmeshed within a prominent fibrotic stroma, typically in a medullary location.
![Page 102: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/102.jpg)
![Page 103: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/103.jpg)
Staging guidelines for kidney cancer are as follows (2.5 cm equals approximately 1 in):
Stage I: Primary tumor is 5 cm or less in greatest dimension and is limited to the kidney, with no lymph node involvement.
Stage II: Primary tumor is larger than 5 cm in greatest dimension and is limited to the kidney, with no lymph node involvement.
![Page 104: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/104.jpg)
Stage III: Primary tumor may extend into major veins or invade adrenal glands or perinephric tissues, but not beyond Gerota's fascia. There may be metastasis in a single lymph node.
Stage IV: Primary tumor invades beyond Gerota's fascia. Metastasis in more than one lymph node. Possible metastasis to distant structures in the body.
![Page 105: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/105.jpg)
![Page 106: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/106.jpg)
The five year survival rate is around 90-95% for tumors less than 4 cm.
For larger tumors confined to the kidney without venous invasion, survival is still relatively good at 80-85%.
For tumors that extend through the renal capsule and out of the local fascial investments, the survivability reduces to near 60%.
![Page 107: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/107.jpg)
If it has metastasized to the lymph nodes, the 5-year survival is around 5 % to 15 %.
If it has spread metastatically to other organs, the 5-year survival rate is less than 5 %.
For those that have tumor recurrence after surgery, the prognosis is generally poor.
Renal cell carcinoma does not generally respond to chemotherapy or radiation.
![Page 108: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/108.jpg)
Immunotherapy, which attempts to induce the body to attack the remaining cancer cells, has shown promise.
Recent trials are testing newer agents, though the current complete remission rate with these approaches are still low, around 12-20% in most series.
![Page 109: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/109.jpg)
![Page 110: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/110.jpg)
Chemotherapy is not commonly used to manage metastasized renal cell carcinoma (mRCC) due to it relatively low response rate
New knowledge about molecular mechanisms involved in the development and metastasis of RCC is expanding available therapeutic options
Cytokine therapy (IL-2) has been the standard for managing mRCC
Several promising new anti-angiogenic and multitarget agents are demonstrating activity in mRCC. They work by binding to different growth factor receptors
![Page 111: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/111.jpg)
Treatment The application of newly acquired
molecular knowledge is helping us shift the management paradigm from palliation to disease control
For non-metastasized cases, roughly 90% can be cured with surgery
After the CA spreads to local lymph nodes, adjunctive therapy would be required
RCC responses well to immunotherapy with interleukin 2 or interferon alpha
![Page 112: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/112.jpg)
Surgery Small renal tumors (<4cm) are treated
with partial nephrectomy Laparoscopic cryotherapy can also be
done on smaller lesions Kidneys can be embolized prior to
surgery to minimized blood loss Tumors >5cm has greater chances of
distance metastases and surgical removal of all or part of the kidney is recommended
![Page 113: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/113.jpg)
Medications RCC elitcits an immune response which
results in sponstaneous remissions Reproduce this response in treatment by using
immunomodulating therapies such as cancer vaccines and IL-2
Restore the function of VHL gene to destroy the proteins that promote inappropriate vascularization. Bevacizumab, an antibody to VEFG has significantly prolonged time to progression
Sunitinib and Sorafenib are drugs that interfere with tumor growth by inhibiting angiogenesis and cell proliferation
![Page 114: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/114.jpg)
Chemotherapy
Most currently available cytostatics are ineffective for the treatment of RCC
The response rate s are very low (5-15%)
![Page 115: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/115.jpg)
Cancer Vaccine
No RCC tumor vaccine in the market yet TroVax has shown promising results in
phase 2 trials
![Page 116: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/116.jpg)
Care for Patients Undergoing Treatment Chemotherapy related side effects are mild
and manageable. They are related to the cytotoxic effects on normal cells that have rapid turnover rate
Cytokine induced symptoms are dose limiting
Side effects associated with targeted and multi-targeted agents are usually mild and can be treated symptomatically. They are reversible on discontinuation of therapy
![Page 117: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/117.jpg)
Common Problems with RCC Treatment and Their ManagementGeneral Problem Management Patient Teaching
Points
Fatigue Encourage patient to rest and to pace activities in accordance with energy level
Ask patient to use log diary to monitor trends and keep note of aggravating and alleviating factors
Mucositis Assess incidence and severity using standard grading scale; observe for infectious complicationsUse anti-infective agents
Discontinue use of tobacco and alcoholApply topical anesthetics
Nausea and vomitting Assess seerity with rating scaleAdminister antiemetic agents
Dietary interventionsAvoid fatty and high salt foods
![Page 118: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/118.jpg)
General Problems with RCC Treatment and Their ManagementGeneral Problem Management Patient Teaching
Points
Diarrhea Give antidiarrhea, antimotility and anticholinergic agentsModified diet and increase fluid intake
Instruct patient to recognize sign and symptoms that require immediate medical attention: fever, palpitation, thirst, cramping
Anorexia Monitor weightReferral to a nutritionistPrescribe enteral supplements
Encourage patient to eat small meals but more frequently
![Page 119: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/119.jpg)
Hematologic Problems with RCC Treatment and Their ManagementHematologic Problem Management Patient Teaching
Points
Anemia Monitor hemoglobin and hematocrit levelsAdminister RBC growth factors as needed
Ask patient to report dizziness, SOB fatigue
Neutropenia Monitor WBCAdminister WBC growth factors as needed
Ask patient to report temp elevation above 100FStress handwashing and avoid crowded places
Thrombocytopenia Monitor platelet countObserve signs of bleeding
Avoid activities that could impare skin and mucous membrane integrity
![Page 120: Differential diagnosis of Kidney mass](https://reader034.fdocuments.us/reader034/viewer/2022051513/546a9865b4af9f7f2c8b47a4/html5/thumbnails/120.jpg)
Integumentary Problems with RCC Treatment and Their ManagementIntegumentary Problem Management Patient Teaching
Points
Hair changes Discuss impact of hair loss and self image
Skin rashes Assess severity with grading scalePrescribe anti infective creams
Ask patient to report potential skin changesAvoid sun exposure
Hand-foot syndrome Assess severity with grading scaleDiscontinue or modify therapy if problem is severe
Apply skin moisturizer creamAvoid activities that put pressure on feet and handsAvoid heat and hot water